New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
A window into the changing tumor microenvironment

A window into the changing tumor microenvironment

by Ludwig Cancer ResearchGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104570Researchers led by Ludwig Lausanne's Anoek Zomer, Davide Croci and Johanna Joyce
Oncology February 18,2024
A window into the changing tumor microenvironment

A window into the changing tumor microenvironment

by Ludwig Cancer ResearchGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104570Researchers led by Ludwig Lausanne's Anoek Zomer, Davide Croci and Johanna Joyce
Oncology February 18,2024
Genetic variation explains racial disparity in esophageal cancer cases

Genetic variation explains racial disparity in esophageal cancer cases

by University of California - San DiegoCredit: Pradipta Ghosh et al,JCI Insight(2022). DOI: 10.1172/jci.insight.161334Esophageal adenocarcinoma (EAC) is a type of cancer affecting the
Oncology February 18,2024
Genetic variation explains racial disparity in esophageal cancer cases

Genetic variation explains racial disparity in esophageal cancer cases

by University of California - San DiegoCredit: Pradipta Ghosh et al,JCI Insight(2022). DOI: 10.1172/jci.insight.161334Esophageal adenocarcinoma (EAC) is a type of cancer affecting the
Oncology February 18,2024
Study identifies risk factors for early onset colorectal cancer in males

Study identifies risk factors for early onset colorectal cancer in males

by Regenstrief InstituteCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer incidence and deaths are declining for individuals age 50 and older, but
Oncology February 18,2024
Study identifies risk factors for early onset colorectal cancer in males

Study identifies risk factors for early onset colorectal cancer in males

by Regenstrief InstituteCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0Colorectal cancer incidence and deaths are declining for individuals age 50 and older, but
Oncology February 18,2024
Researchers chart a course for understanding, preventing and treating young-onset colorectal cancer

Researchers chart a course for understanding, preventing and treating young-onset colorectal cancer

by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainColorectal cancer among young people is increasing globally and rapidly. Experts expect it to become the leading cause of cancer d
Oncology February 18,2024
Researchers chart a course for understanding, preventing and treating young-onset colorectal cancer

Researchers chart a course for understanding, preventing and treating young-onset colorectal cancer

by Dana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainColorectal cancer among young people is increasing globally and rapidly. Experts expect it to become the leading cause of cancer d
Oncology February 18,2024
Examining a potential second generation epigenetic therapy for advanced solid tumors

Examining a potential second generation epigenetic therapy for advanced solid tumors

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPreliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential sec
Oncology February 18,2024
Examining a potential second generation epigenetic therapy for advanced solid tumors

Examining a potential second generation epigenetic therapy for advanced solid tumors

by Vall d'Hebron Institute of OncologyCredit: Unsplash/CC0 Public DomainPreliminary results of a first-in-human study show manageable toxicity and preliminary antitumor activity of a potential sec
Oncology February 18,2024
Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

by Vall d'Hebron Institute of OncologyLaura Soucek, co-Director of Preclinical and Translational Research at VHIO, Chief Executive Officer of Peptomyc, and an ICREA Research Professor. Credit: VHI
Oncology February 18,2024
Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

Inhibitor shows lasting structural integrity and long terminal half-life in tumor tissue

by Vall d'Hebron Institute of OncologyLaura Soucek, co-Director of Preclinical and Translational Research at VHIO, Chief Executive Officer of Peptomyc, and an ICREA Research Professor. Credit: VHI
Oncology February 18,2024
Researchers discover how melanoma changes its environment to support metastasis

Researchers discover how melanoma changes its environment to support metastasis

by Tel-Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study conducted at Tel Aviv University and the Sheba Medical Center reveals how melanoma cancer cells affect their close environment t
Oncology February 18,2024
Researchers discover how melanoma changes its environment to support metastasis

Researchers discover how melanoma changes its environment to support metastasis

by Tel-Aviv UniversityCredit: Pixabay/CC0 Public DomainA new study conducted at Tel Aviv University and the Sheba Medical Center reveals how melanoma cancer cells affect their close environment t
Oncology February 18,2024
Better adenoma detection using a molecular marker for fluorescent imaging

Better adenoma detection using a molecular marker for fluorescent imaging

by Sarah E. Glass,Vanderbilt University(a)Representative white light and corresponding fluorescence colonoscopy images (static) of B6;129 mice bearing either colorectal adenomas or normal
Oncology February 18,2024
Better adenoma detection using a molecular marker for fluorescent imaging

Better adenoma detection using a molecular marker for fluorescent imaging

by Sarah E. Glass,Vanderbilt University(a)Representative white light and corresponding fluorescence colonoscopy images (static) of B6;129 mice bearing either colorectal adenomas or normal
Oncology February 18,2024
Researchers identify protein that may protect the heart during certain cancer treatment regimens

Researchers identify protein that may protect the heart during certain cancer treatment regimens

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterCirculating Hpx is elevated in mice treated with Dox. (A) Dox-induced chronic cardiomyopathy model in mice. i.p., intraperitoneally. (B
Oncology February 18,2024
Researchers identify protein that may protect the heart during certain cancer treatment regimens

Researchers identify protein that may protect the heart during certain cancer treatment regimens

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterCirculating Hpx is elevated in mice treated with Dox. (A) Dox-induced chronic cardiomyopathy model in mice. i.p., intraperitoneally. (B
Oncology February 18,2024
Study identifies new gene that drives colon cancer

Study identifies new gene that drives colon cancer

by The Mount Sinai HospitalRecurrently dysregulated super-enhancers in CRC patients.aStudy overview. Figure adapted from SMART Servier Medical Art, reproduced with permission, license
Oncology February 18,2024
Study identifies new gene that drives colon cancer

Study identifies new gene that drives colon cancer

by The Mount Sinai HospitalRecurrently dysregulated super-enhancers in CRC patients.aStudy overview. Figure adapted from SMART Servier Medical Art, reproduced with permission, license
Oncology February 18,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com